Haval Shirwan

Affiliations: 
University of Louisville, Louisville, KY, United States 
Area:
Immunology, Biochemistry, Molecular Biology
Google:
"Haval Shirwan"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ramos-Gonzalez MR, Tarique M, Batra L, et al. (2024) Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth. Vaccines. 12
Gulen AE, Rudraboina R, Tarique M, et al. (2023) A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer. Cancer Immunology, Immunotherapy : Cii. 72: 3567-3579
Coronel MM, Linderman SW, Martin KE, et al. (2023) Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Shrestha P, Turan A, Batra L, et al. (2023) Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease. Blood Advances
Medina JD, Barber GF, Coronel MM, et al. (2022) A hydrogel platform for co-delivery of immunomodulatory proteins for pancreatic islet allografts. Journal of Biomedical Materials Research. Part A
Coronel MM, Martin KE, Hunckler MD, et al. (2020) Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival. Science Advances. 6: eaba5573
Shrestha P, Batra L, Tariq Malik M, et al. (2020) Immune checkpoint CD47 molecule engineered islets mitigate instant blood-mediated inflammatory reaction and show improved engraftment following intraportal transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Batra L, Shrestha P, Zhao H, et al. (2020) Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression. Journal of Immunology (Baltimore, Md. : 1950)
Shirwan H, Batra L, Malik MT, et al. (2020) Abstract 4516: SA-4-1BBL as a novel agonist of CD137 has immunoprevention efficacy against various tumor types Immunology. 80: 4516-4516
Batra L, Shrestha P, Zhao H, et al. (2020) Immunomodulation With Sa-Pdl1 Protein On Pancreatic Islets Promotes Indefinite Graft Survival In Allogeneic Recipients Transplantation. 104
See more...